Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $94.63M.
ENTERPRISE VALUE (EV)
$94.63M
ImmuCell Corporation
Market Cap
$89.34M
Enterprise Value (EV)
$94.63M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ImmuCell Corporation (ICCC) | $89.34M | $94.63M |
| Rallybio Corporation (RLYB)vs › | $89.36M | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.46M | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | $77.35M |
| electroCore, Inc. (ECOR)vs › | $90.16M | $91.22M |
| Equillium, Inc. (EQ)vs › | $90.73M | $34.15M |
| Biomea Fusion, Inc. (BMEA)vs › | $91.30M | $57.35M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.95M | $93.61M |
| CareCloud, Inc. (CCLD)vs › | $86.90M | $127.52M |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.48M | N/A |
Market Cap
$89.34M
Total Debt
$9.10M
Cash
$3.81M
Enterprise Value
$94.63M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute